Breast cancer screening programs and full-field digital mammography (FFDM) in the European market are set to experience growth due to breast cancer being identified as one of the leading causes of death among European women, according to an analysis from Frost & Sullivan of San Jose, CA.
Frost noted that several governments have launched extensive screening and awareness programs across the continent. The firm points to the success of screening programs in Sweden and the Netherlands, where mobile mammography units have contributed to the expansion of the market.
The FFDM segment did not meet initial growth predictions. However, Frost believes that as manufacturers demonstrate FFDM's advantages over conventional film-based mammography, the market segment will take off.
The report, European Mammography Systems Market, states that because FFDM systems cost as much as five times the price of analog systems, the segment has excellent potential to increase the profit margins of market participants.
By AuntMinnie.com staff writers
January 18, 2005
Related Reading
Healthcare IT regulations to drive European IS market, January 11, 2005
HIPAA, data deluge driving U.S. storage market, December 7, 2004
CAD systems show double-digit growth in Europe, November 23, 2004
CT and MRI taking over x-ray's volume, report says, November 16, 2004
European contrast market shows volatility, October 21, 2004
Copyright © 2005 AuntMinnie.com

![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)







![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)








